http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008148493-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb761f60a9fed43f66800c15d5a45f71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a974d908caa41567d1a16d4bf786ffa1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4718 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f02bb36676b4d00e8e8b91bf7130b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_891aaa83113406291998ec2cc5e20b19 |
| publicationDate | 2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2008148493-A2 |
| titleOfInvention | Annexin a5 and annexin a6 as biomarkter for alzheimer's disease |
| abstract | The present invention relates to a method for assessing Alzheimer's disease in vitro comprising measuring in a sample (e.g. body fluid) the level of one or more proteins of the group consisting of Annexin A5 and Annexin A6, or a variant thereof, wherein an altered level of said one or more proteins, or a variant thereof, is indicative that said individual suffers from Alzheimer's Disease. Furthermore, the present invention relates to a method for monitoring the progression of the Alzheimer's disease in vitro comprising measuring in a sample (e.g. body fluid) the level of one or more proteins of the group consisting of Annexin A5 and Annexin A6, or a variant thereof, wherein an altered level of said one or more proteins, or a variant thereof, compared with an earlier measurement of the level of said one or more proteins, or a variant thereof, is indicative for the progression of Alzheimer's disease. |
| priorityDate | 2007-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 231.